Does LDL-apheresis in steroid-resistant nephrotic syndrome affect prognosis?

Nephrology Dialysis Transplantation

Volumn 9, Issue 3, 1994, Pages 257-264

  Muso, E ^a   Yashiro, M ^a   Sasayama, S ^a   Matsushima, M ^b   Yoshida, H ^c  

^a Department of Internal Medicine ^*  (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION HIMEJI MEDICAL CENTER   (Japan)

Author keywords

Focal glomerular sclerosis; Hyperlipidaemia; LDL apheresis; Macrophage; Nephrotic syndrome

Indexed keywords

ANTILIPEMIC AGENT; APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; PHOSPHOLIPID; SERUM ALBUMIN; TRIACYLGLYCEROL;

ADULT; APHERESIS; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL FEATURE; DRUG RESISTANCE; FEMALE; FOCAL GLOMERULOSCLEROSIS; GLOMERULUS; HUMAN; HUMAN TISSUE; HYPERLIPIDEMIA; IMMUNOHISTOLOGY; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE; LIPOPROTEIN BLOOD LEVEL; MACROPHAGE; MALE; MESANGIUM; NEPHROTIC SYNDROME; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; RETROSPECTIVE STUDY; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; APOLIPOPROTEINS B; APOLIPOPROTEINS E; BLOOD COMPONENT REMOVAL; DRUG RESISTANCE; FEMALE; GLOMERULONEPHRITIS, MEMBRANOUS; GLOMERULOSCLEROSIS, FOCAL; HUMAN; LIPOPROTEINS, LDL; MACROPHAGES; MALE; MIDDLE AGE; NEPHROSIS, LIPOID; NEPHROTIC SYNDROME; PROGNOSIS; STEROIDS;

EID: 0028348953     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a092835     Document Type: Article

References (34)

1. Cameron JS, Turner DR, Ogg CS et al. The longterm prognosis of patients with focal segmental glomerulosclerosis. Clin Nephrol 1978; 10: 213-218
2. Velosa JA, Holly K.E, Torres VE et al. Significance of proteinuria on the outcome of renal function in patients with focal segmental glomerulosclerosis. Mayo Clin Proc 1983; 58: 568-577
3. Kohaut EC, Edwards GA, Hill LL et al. Focal glomerulosclerosis: extent of involvement related to steroid resistance. Am J Clin Pathol 1981; 75: 181-185
4. Brown CB, Cameron JS, Turner DR et al. Focal segmental glomerulosclerosis with rapid decline in renal function (‘malignant FSGS’). Clin Nephrol 1978; 10: 51-61
5. Diamond JR, Karmousky MJ. Editorial Review: Focal and segmental glomerulosclerosis: Analogies to atherosclerosis. Kidney Int 1988; 33: 917-924
6. Moorhead JF, Chan MK, El-Nahas M et al. Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet 1982; 2: 1309-1311
7. Alexander JH, Schapel GJ, Edwards KDG. Increased incidence of coronary heart disease associated with combined elevation of serum triglyceride and cholesterol concentrations in the nephrotic syndrome in man. Med J Aust 1974; 2: 119-122
8. Curry RC Jr, Roberts WC. Status of the coronary arteries in the nephrotic syndrome: analysis of 20 necropsy patients aged 15 to 35 years to determine if coronary atherosclerosis is accelerated. Am J Med 1977; 63: 183-192
9. lida H, Asaka M, Fujita M et al. Effect of probucol on hyperlipidemia in patients with nephrotic syndrome. Nephron 1987; 47: 280-283
10. Harris LCPG, Pukerson ML, Yates J et al. Lovastatin ameliorates the development of glomerulosclerosis and uremia in experimental nephrotic syndrome. Am J Kidney Dis 1990; 15: 16-23
11. Mabuchi H, Michishita I, Takeda M et al. A new density lipoprotein apheresis system using two dextran sulfate cellulose columns in an automated column regenerating unit (LDL continuous apheresis). Atherosclerosis 1987; 68: 19-25
12. Yokoyama S, Yamamoto A, Hayashi R et al. LDL-apheresis; potential procedure for prevention and regression of atheromatous vascular lesion. Jpn Cir J 1987; 51: 1116-1122
13. Pulford JCAF, Rigney EM, Micklem KJ et al. KP1: a new monoclonal antibody that detects a monocyte/macrophage associated antigen in routinely processed tissue sections. J Clin Pathol 1989; 42: 414-421
14. Habib R. Editorial: Focal glomerular sclerosis. Kidney Int 1973; 4: 355-361
15. Beaufils H, Alphonse JC, Guedon J et al. Focal glomerulosclerosis: Natural history and treatment. Nephron 1978; 21: 75-85
16. Fogo A, Hawkins EP, Berry PL et al. Glomerular hypertrophy in minimal change disease predicts subsequent progression to focal glomerular sclerosis. Kidney Int 1990; 38: 115-123
17. Siegel NJ, Gaudio KM, Krassner LS et al. Steroid-dependent nephrotic syndrome in children: histopathology and relapses after cyclophosphamide treatment. Kidney Int 1981; 19: 454—459
18. Wakai S, Magil AB. Focal glomerulosclerosis in idiopathic membranous glomerulonephritis. Kidney Int 1992; 41: 428—434
19. Korbet SM, Schwartz MM, Lewis EJ. The prognosis of focal segmental glomerular sclerosis of adulthood. Medicine 1986; 65: 304-311
20. Keane WF, O’donnell MP, Kasiske BL et al. Lipids and the progression of renal disease. J Am Soc Nephrol 1990; 1: S69-S74
21. Anderson S, King AJ, Brenner BM. Hyperlipidemia and glomerular sclerosis: an alternative viewpoint. Am J Med 1989; 87: 5-34N-38N
22. Tojo K, Sakai S, Miyahara T. Possible therapeutic application of double filtration plasmapheresis (DFPP) in drug-resistant nephrotic syndrome due to focal glomerular sclerosis (FGS). Jpn J Nephrol 1988; 30: 1153-1160
23. Smith JD, Hayslett JP. Reversible renal failure in the nephrotic syndrome. Am J Kidney Dis 1992; 19: 201-213
24. Carrie BJ, Golbetz HV, Michaels AS et al. Creatinine: An inadequate filtration marker in glomerular diseases. Am J Med 1980; 69: 177-182
25. Faraggiana T, Churg J. Renal lipidoses: a review. Hum Pathol 1987; 18: 661-679
26. Wasserman J, Santiago A, Rifici V et al. Interactions of low density lipoprotein with rat mesangial cells. Kidney Int 1989; 35: 1168-1174
27. Grone HJ, Walli AK, Grone E et al. Receptor mediated uptake of apo B and apo E rich lipoproteins by human glomerular epithelial cells. Kidney Int 1990; 37: 1449-1459
28. Rayner HC, Horrsburgh T, Brown SL et al. Receptor-mediated endocytosis of lower-density lipoprotein by cultured human glomerular cells. Nephron 1990; 55: 292-299
29. Diamond JR, Pesek I, McCarter MD et al. Altered functional characteristics of rat macrophages during nephrosis. Am J Pathol 1989; 135: 711-718
30. Magil AB, Fröhlich JJ. Monocytes and macrophages in focal glomerulosclerosis in Zucker rats. Nephron 1991; 59: 131-138
31. Kelly JL, Rozek MM, Suenram CA et al. Activation of human peripheral blood monocytes by lipoproteins. Am J Pathol 1988; 130: 223-229
32. Schreiner GF, Cotran RS, Unanue ER. Modulation of la and leukocyte common antigen expression in rat glomeruli during the course of glomerulonephritis and aminonucleoside nephrosis. Lab Invest 1984; 51: 524-533
33. Diamond JR, Pesek I, Ruggieri S et al. Essential fatty acid deficiency during acute puromycin nephrosis ameliorates late renal injury. Am J Physiol 1989; 257: F798-F807
34. Kasiske BL, O’donnell MP, Garvis WJ et al. Pharmacologic treatment of hyperlipidemia reduces glomerular injury in rat 5/6 nephrectomy model of chronic renal failure. Cir Res 1988; 62: 367-374